Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process

J Surg Oncol. 2021 Sep;124(3):453-454. doi: 10.1002/jso.26508. Epub 2021 Apr 20.

Authors

Amine Souadka¹, Hajar Habbat¹, Mohammed Anass Majbar¹, Amine Benkabbou¹, Laila Amrani¹, Abdelilah Ghannam², Brahim El Ahmadi², Zakaria Houssaïn Belkhadir², Raouf Mohsine¹

Affiliations

¹ Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco.
² Intensive Care Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / etiology
COVID-19 / prevention & control*
COVID-19 Vaccines*
Health Services Accessibility*
Humans
Neoplasms / complications*
Neoplasms / immunology
Risk Assessment
Risk Factors

Substances

COVID-19 Vaccines